(Q34708416)

4 August 2017

Tetrahydrocannabinol for tremor in multiple sclerosis (English)

1 reference

4 August 2017

0 references

0 references

0 references

1 reference

https://api.crossref.org/works/10.1002/ANA.410130616

23 September 2023

author name string

D. B. Clifford

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6309074

23 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6309074

23 September 2023

publication date

1 June 1983

1 reference

full work available at URL

4 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410130616

1 reference

https://api.crossref.org/works/10.1002/ANA.410130616

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410130616

23 September 2023

1 reference

https://api.crossref.org/works/10.1002/ANA.410130616

23 September 2023

1 reference

4 August 2017

13

1 reference

4 August 2017

669-671

1 reference

4 August 2017

6

1 reference

Criteria for the clinical diagnosis of multiple sclerosis

4 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FANA.410130616

Cannabinoids And The Cholinergic System

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1002/ANA.410130616

Δ9-Tetrahydrocannabinol-induced changes in β-adrenergic receptor binding in mouse cerebral cortex

23 September 2023

3

1 reference

https://api.crossref.org/works/10.1002/ANA.410130616

FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS

23 September 2023

4

1 reference

https://api.crossref.org/works/10.1002/ANA.410130616

Treatment of Human Spasticity with Δ9-Tetrahydrocannabinol

23 September 2023

5

1 reference

https://api.crossref.org/works/10.1002/ANA.410130616

23 September 2023

Identifiers

1 reference

4 August 2017

1 reference